Exosomal PD-L1 (exoPD-L1) is highly immunosuppressive on T cell-mediated anti-tumor immunity in many types of cancers including melanoma, NSCLC, prostate and breast cancers, and many other types of cancers [284,285,286]. This evidence concerns the gene CD274 and cancer.